Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Change in Cash (2016 - 2026)

Neuroone Medical Technologies filings provide 15 years of Change in Cash readings, the most recent being -$757605.0 for Q1 2026.

  • On a quarterly basis, Change in Cash fell 507.53% to -$757605.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 million, a 233.14% increase, with the full-year FY2025 number at $5.1 million, up 232.31% from a year prior.
  • Change in Cash hit -$757605.0 in Q1 2026 for Neuroone Medical Technologies, up from -$3.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $6.7 million in Q2 2025 to a low of -$3.5 million in Q4 2022.
  • Median Change in Cash over the past 5 years was -$814678.0 (2024), compared with a mean of -$787077.2.
  • The widest YoY moves for Change in Cash: up 924.8% in 2025, down 823.81% in 2025.
  • Neuroone Medical Technologies' Change in Cash stood at -$3.5 million in 2022, then grew by 24.37% to -$2.6 million in 2023, then soared by 87.67% to -$325692.0 in 2024, then crashed by 823.81% to -$3.0 million in 2025, then surged by 74.82% to -$757605.0 in 2026.
  • The last three reported values for Change in Cash were -$757605.0 (Q1 2026), -$3.0 million (Q4 2025), and -$1.5 million (Q3 2025) per Business Quant data.